From August 26 to 29, 2025, Tam Anh General Hospital Group, in collaboration with Tam Anh Research Institute (TAMRI), hosted the International Scientific Conference on Quality Assurance and Quality Control (QA/QC) in Radiation Therapy – Integrating Comprehensive IBA Solutions, sharing the latest QA/QC advancements, aiming to deliver precise and maximally safe radiation therapy for cancer patients.
Dr. Eduard Gershkevitsh, Head of the Department at North Estonia Medical Centre, shares global radiation safety standards. Photo: Tam Anh General Hospital.
The conference featured distinguished speakers including Dr. Eduard Gershkevitsh, Head of the Department at North Estonia Medical Centre, Ms. Rebecca Annette Stumpf, Clinical Application Specialist from IBA Dosimetry GmbH (Germany), and a wide range of engineers and experts from Tam Anh General Hospital Group, Cho Ray Hospital, Ho Chi Minh City Oncology Hospital, Military Hospital 175, FV Hospital, Hue Central Hospital, K Hospital, Hanoi Oncology Hospital, Phenikaa Hospital, and others.
Dr. Eduard Gershkevitsh emphasized that dose accuracy is the core factor directly influencing treatment efficacy and safety. Achieving this requires comprehensive QA/QC implementation—from reference dose measurement, accelerator calibration, treatment planning systems, to patient-specific quality control. QA/QC is not merely a technical process but a commitment to ensuring patient safety and effective treatment.
According to IAEA guidelines (TRS-398, TRS-483), standardized dosimetry and equipment calibration can reduce uncertainty in high-energy photon dose measurements to approximately 1.5% — a clinically acceptable threshold and a critical foundation for improving radiation therapy outcomes.
The conference hosts a series of hands-on workshops with linear accelerators, offering participants practical experiences. Photo: Tam Anh General Hospital.
At the Conference, Ms. Rebecca Annette Stumpf introduced IBA Dosimetry’s comprehensive QA/QC ecosystem as a leading solution for enhancing quality and standardizing verification procedures in radiation therapy.
The system included dose measurement and multi-dimensional phantoms for machine calibration, the myQA software for centralized and transparent data management, and scheduled QA procedures for Linac and CT simulators to ensure stable operation. In addition, patient-specific QA (PSQA), aligned with TG-218 standards, is also integrated to support advanced techniques such as IMRT, VMAT, and SBRT/SRS.
Tam Anh General Hospital Group has invested extensively and systematically in these cutting-edge devices and technologies. Their implementation helps minimize errors, streamline verification, enhance reliability, and elevate treatment quality to international standards.
In addition to scientific presentations, the conference held a series of practical workshops, offering the participants direct hands-on experience. Topics included updates on international QA/QC standards, introduction to the myQA ecosystem, hands-on calibration and verification of Linac and CT simulators, demonstrations of QA software and procedures for VMAT and SRS techniques.
Particularly, the participants also gained hands-on experience in Motion QA for complex scenarios such as 4D, DIBH, gating, and tracking, ensuring maximum safety in mobile tumor treatment. These practical sessions were highly praised for their applicability, helping medical professionals master new technologies, thoroughly understand protocols, and confidently implement them in clinical settings.
Dr. Eduard Gershkevitsh and Ms. Rebecca Annette Stumpf guide participants through practical QA/QC procedures. Photo: Tam Anh General Hospital.
Several reports highlighted advanced QA tools such as PSQA with 3%/2mm Gamma analysis, End-to-End testing, 3D DVH, and independent dose calculations using Monte Carlo simulations. These tools are essential for accurately controlling dose distribution, ensuring maximal tumor control (PTV), while safeguarding healthy organs (OAR).
Experts widely agreed that the future of QA/QC in modern radiation therapy lies in the integration of international standards, advanced measurement tools, 3D data analysis, and independent computational algorithms. This comprehensive approach establishes a robust QA/QC framework that is closely tied to patient safety and optimal treatment efficacy.
The International Scientific Conference on QA/QC in Radiation Therapy, featuring IBA’s integrated solutions, served not only as a prestigious academic forum but also as a platform for knowledge transfer, technology exchange, and hands-on learning. With the participation of leading experts and IBA’s comprehensive QA ecosystem, the conference has helped shape a safer, more precise, and more effective QA/QC landscape in Vietnam, with the ultimate goal of optimizing treatment outcomes for cancer patients.
Tam Anh Research Institute
15/03/2025
View more
